Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TRUST: Urokinase Thrombolysis vs Antiplatelets for Minor Stroke
NCT04420351Phase 3Completed
- Sponsor
- The First Affiliated Hospital of Zhengzhou University
- Start
- Oct 2020
- Primary completion
- Feb 2023
- Modality
- Therapeutic Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of urokinase in ischemic stroke, sponsored by The First Affiliated Hospital of Zhengzhou University. Started Oct 2020; status: completed.
02
Drugs
urokinase
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT04420351.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04420351.